Join
Live feed
·
INSIDERFilingvia Quantisnow
Beta Bionics Inc. logo

Chief Commercial Officer Hopman Mark sold $101,815 worth of shares (5,327 units at $19.11), decreasing direct ownership by 4% to 124,027 units (SEC Form 4) (withholding obligation)

ByQuantisnow·Wall Street's wire, on your screen.
BBNX· Beta Bionics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBNX (Beta Bionics Inc.) and more on Quantisnow.